CardioFocus has announced milestones related to its pulsed field ablation technology, including first enrollments in a clinical trial for its QuickShot catheter and CardioWave system. The company has also reported on various other developments, including late-breaking data and expanded clinical programs, as well as clearance and approvals for its HeartLight systems in the US and Europe. The specific outcomes and details of these developments are not consistently reported across the announcements.